Surgical treatment of HCC in a patient with lamivudine-resistant hepatitis B cirrhosis with adefovir dipivoxil

Table 1 Laboratory data on admission

Blood chemistry	Value	Hematological analysis	Value	Viral markers	Value	Coagulation	Value	Tumor markers	Value
TP (g/dL)	7.8	WBC (× 103/L)	3.60	HBs Ag (IU/mL)	5.56	PT (%)	67	AFP (ng/dL)	< 5
Alb (g/dL)	4.1	RBC (× 106/L)	4.59	HBs Ab (mIU/mL)	1.20			PIVKA-II (mAU/mL)	22
AST (IU/dL)	33.0	Hb (g/dL)	13.00	HBe Ag (S/CO)	0.30
ALT (IU/dL)	28.0	Ht (%)	40.60	HBe Ab (%Inh)	89.60
LDH (IU/dL)	168.0	Plt (× 103/L)	8.80	HBV-DNA	Undetectable
ALP (IU/dL)	313.0
GGT (IU/dL)	30.0
T-bil (mg/dL)	0.6
ZTT (KKU)	8.7

TP: total protein; Alb: albumin; AST: aspartate aminotransferase; ALT: alanine aminotransferase; LDH: lactic dehydrogenase; ALP: alkaline phosphatase; GGT: gamma-glutamyl transpeptidase; T-bil: total bilirubin; ZTT: zinc turbidity test; WBC: while blood cells; RBC: red blood cells; Hb: hemoglobin; Ht: hematocrit; Plt: platelets; PT: prothrombin time; AFP: alpha-fetoprotein; PIVKA-II: protein induced by vitamine K absence or antagonist-II.